Getting Closer to Effective Targeted Immunotherapies for Myasthenia Gravis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Current Opinion in Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Progress in the Therapy of Myasthenia Gravis: Getting Closer to Effective Targeted Immunotherapies
Curr. Opin. Neurol 2020 Oct 01;33(5)545-552, MC DalakasFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.